SCHEMBL25367668

SCHEMBL25367668

O=C(OCc1ccccc1)c1cc(F)c(OCc2ccccc2)c(F)c1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
TDP1 Q9NUW8 3/20 0.50
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 3/20 0.45
LMNA P02545 2/20 0.45
TSHR P16473 2/20 0.45
HPGD P15428 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25365036 0.87 CTSV (0.52) ALDH1A1TDP1KMT2APOLBL3MBTL1
SCHEMBL4145578 0.83 ALDH1A1 (0.58) ALDH1A1TDP1SLC6A2SLC6A3KMT2A
SCHEMBL18782372 0.82 ALDH1A1 (0.64) ALDH1A1TDP1SLC6A2SLC6A3KMT2A
SCHEMBL25359554 0.80 KDM1A (0.49) SLC6A2SLC6A3LMNATSHRHPGD
SCHEMBL20607847 0.80 MEN1 (0.47) ALDH1A1TDP1KMT2APOLBL3MBTL1
SCHEMBL27741010 0.80 MEN1 (0.47) ALDH1A1TDP1KMT2AL3MBTL1LMNA
SCHEMBL24010741 0.79 ALDH1A1 (0.60) ALDH1A1TDP1SLC6A2SLC6A3KMT2A
SCHEMBL24983872 0.79 MEN1 (0.48) ALDH1A1TDP1KMT2APOLBL3MBTL1
SCHEMBL7588876 0.79 ALDH1A1 (0.53) ALDH1A1TDP1SLC6A2SLC6A3KMT2A
SCHEMBL8564183 0.79 MAOB (0.52) TDP1L3MBTL1LMNAHPGDCTSV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240083853-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, INC. 2024-03-14 US disclosed
CN-116600801-A HSD17B13 inhibitors and uses thereof FL2022-001公司 2023-08-15 CN disclosed
EP-4221701-A1 HSD17B13 INHIBITORS AND USES THEREOF FL2022-001, Inc. (US) 2023-08-09 EP disclosed
WO-2022072491-A1 HSD17B13 INHIBITORS AND USES THEREOF METACRINE, INC. (US) 2022-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083853-A1 HSD17B13 INHIBITORS AND USES THEREOF HSD17B3, HSD17B11, HSD17B1 ALDH1A1 247/4885TDP1 1184/4885SLC6A2 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.